Fetal fibronectin test for threatened preterm delivery 48h after admission: Cost-effectiveness study.
Cost-effectiveness analysis
Fibronectin
Preterm delivery
Journal
European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
12
09
2018
revised:
24
12
2018
accepted:
27
12
2018
pubmed:
21
1
2019
medline:
31
5
2019
entrez:
21
1
2019
Statut:
ppublish
Résumé
The aim of this work was to assess the cost-effectiveness of the fetal fibronectin (fFN) test at 48 h after admission for threatened preterm delivery to promote early discharge. Before-and-after study to calculate the incremental cost-effectiveness ratio (ICER). Patients were enrolled 48 h after admission in a tertiary care centre for threatened preterm delivery between 24 The study included 178 pregnant patient, 99 during the first period (July 2008-October 2009) and 79 during the second (March 2010-February 2012). The lengths of hospital stays were shorter during the second period, with more than 50% of women discharged home between 48 and 72 h (p < 0.0001) resulting in a cost-saving of 76 051 euros. The number of deliveries at 7 and at 14 days was similar between the two periods. The fFN test at 48 h after admission supported early discharge and was safe and cost-effective.
Identifiants
pubmed: 30660942
pii: S0301-2115(19)30034-X
doi: 10.1016/j.ejogrb.2018.12.043
pii:
doi:
Substances chimiques
Fibronectins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-78Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.